Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
Trial · NCT03359356
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in the Severity of Alopecia Tool (SALT) Score at Week 24 | Baseline and 24 weeks | score on a scale | MEAN | |
| SECONDARY | Change From Week 24 in the SALT Score at Week 48 | Week 24 and 48 weeks | score on a scale | MEAN | |
| SECONDARY | Change From Baseline in the SALT Score at Week 48 | Baseline and 48 weeks | score on a scale | MEAN | |
| SECONDARY | Number of Patients Achieving at Least 50% Improvement in Severity of Alopecia Tool (SALT) Score (SALT-50) at Weeks 24 and 48 Compared to Baseline | weeks 24 and 48 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Patients Achieving at Least 75% Improvement in SALT-75 at Weeks 24 and 48 | Weeks 24 and 48 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Patients Achieving at Least 90% Improvement in Severity of Alopecia Tool (SALT) Score (SALT-90) at Weeks 24 and 48 | Weeks 24 and 48 | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Change in Alopecia Areata Symptom Impact Scale (AASIS) | Weeks 24 and 48 | score on a scale | MEAN | |
| SECONDARY | Change in Alopecia Areata Quality of Life Questionnaire | Weeks 24 and 48 | score on a scale | MEAN | |
| SECONDARY | Eyelash/Eyebrow Assessment Score Weeks 12, 24, 36, and 48 Compared to Baseline | Weeks 12, 24, 36, and 48 | One participant had missing eyelash data because of artificial eyelashes (glued on her real eyelashes). | score on a scale | MEAN |
| SECONDARY | Change in EASI Scores From Baseline at Week 24 and 48 | Weeks 24 and 48 | Data for only those participants with eczema. | score on a scale | MEAN |
| SECONDARY | Number of Adverse Events | 48 weeks | events | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03359356/outcomes